A suite of DNA methylation markers that can detect most common human cancers

References

• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–E386. doi:10.1002/ijc.29210. PMID:25220842
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017;67:7–30. doi:10.3322/caac.21387. PMID:28055103
   PubMed Web of Science ®Google Scholar
• Schwarzenbach H, Hoon DSB, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer. 2011;11:426–437. doi:10.1038/nrc3066. PMID:21562580
   PubMed Web of Science ®Google Scholar
• Leon SA, Shapiro B, Sklaroff DM, et al. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res. 1977;37:646–650. PMID:837366
   PubMed Web of Science ®Google Scholar
• Lui YY, Chik KW, Chiu RW, et al. Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. Clin Chem. 2002;48:421–427. PMID:11861434
   PubMed Web of Science ®Google Scholar
• Snyder MW, Kircher M, Hill AJ, et al. Cell-free DNA comprises an in vivo nucleosome footprint that informs its tissues-of-origin. Cell. 2016;164:57–68. doi:10.1016/j.cell.2015.11.050. PMID:26771485
   PubMed Web of Science ®Google Scholar
• Fleischhacker M, Schmidt B. Circulating nucleic acids (CNAs) and cancer–a survey. Biochim Biophys Acta. 2007;1775:181–232. PMID:17137717
   PubMed Web of Science ®Google Scholar
• Jahr S, Hentze H, Englisch S, et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 2001;61:1659–1665. PMID:11245480
   PubMed Web of Science ®Google Scholar
• Diehl F, Li M, Dressman D, et al. Detection and quantification of mutations in the plasma of patients with colorectal tumors. Proc Natl Acad Sci U S A. 2005;102:16368–16373. doi:10.1073/pnas.0507904102. PMID:16258065
   PubMed Web of Science ®Google Scholar
• Warton K, Lin V, Navin T, et al. Methylation-capture and next-generation sequencing of free circulating DNA from human plasma. BMC Genomics. 2014;15:476. doi:10.1186/1471-2164-15-476. PMID:24929644
   PubMed Web of Science ®Google Scholar
• Breitbach S, Tug S, Helmig S, et al. Direct quantification of cell-free, circulating DNA from unpurified plasma. PLoS One. 2014;9:e87838.doi:10.1371/journal.pone.0087838. PMID:24595313
   PubMed Web of Science ®Google Scholar
• Devonshire AS, Whale AS, Gutteridge A, et al. Towards standardisation of cell-free DNA measurement in plasma: controls for extraction efficiency, fragment size bias and quantification. Anal Bioanal Chem. 2014;406:6499–6512. doi:10.1007/s00216-014-7835-3. PMID:24853859
   PubMed Web of Science ®Google Scholar
• Oxnard GR, Paweletz CP, Kuang Y, et al. Noninvasive detection of response and resistance in EGFR-mutant lung cancer using quantitative next-generation genotyping of cell-free plasma DNA. Clin Cancer Res. 2014;20:1698–1705. doi:10.1158/1078-0432.CCR-13-2482. PMID:24429876
   PubMed Web of Science ®Google Scholar
• Bettegowda C, Sausen M, Leary RJ, et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med. 2014;6:224ra24. doi:10.1126/scitranslmed.3007094.
   PubMed Web of Science ®Google Scholar
• Esteller M, Herman JG. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol. 2002;196:1–7. doi:10.1002/path.1024. PMID:11748635
   PubMed Web of Science ®Google Scholar
• Novak P, Jensen T, Oshiro MM, et al. Agglomerative epigenetic aberrations are a common event in human breast cancer. Cancer Res. 2008;68:8616–8625. doi:10.1158/0008-5472.CAN-08-1419. PMID:18922938
   PubMed Web of Science ®Google Scholar
• Shames DS, Girard L, Gao B, et al. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies. PLoS Med. 2006;3:e486. doi:10.1371/journal.pmed.0030486. PMID:17194187
   PubMed Web of Science ®Google Scholar
• Rauch TA, Zhong X, Wu X, et al. High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer. Proc Natl Acad Sci U S A. 2008;105:252–257. doi:10.1073/pnas.0710735105. PMID:18162535
   PubMed Web of Science ®Google Scholar
• Heyn H, Esteller M. DNA methylation profiling in the clinic: applications and challenges. Nat Rev Genet. 2012;13:679–692. doi:10.1038/nrg3270. PMID:22945394
   PubMed Web of Science ®Google Scholar
• Comprehensive molecular portraits of human breast tumours. Nature. 2012;490:61–70. doi:10.1038/nature11412. PMID:23000897
   PubMed Web of Science ®Google Scholar
• Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014;507:315–322. doi:10.1038/nature12965. PMID:24476821
   PubMed Web of Science ®Google Scholar
• Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014;511:543–550. doi:10.1038/nature13385. PMID:25079552
   PubMed Web of Science ®Google Scholar
• Uehiro N, Sato F, Pu F, et al. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer. Breast Cancer Res. 2016;18:129. doi:10.1186/s13058-016-0788-z. PMID:27993161
   PubMed Web of Science ®Google Scholar
• Grutzmann R, Molnar B, Pilarsky C, et al. Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay. PLoS One. 2008;3:e3759. doi:10.1371/journal.pone.0003759. PMID:19018278
   PubMed Web of Science ®Google Scholar
• Lee WH, Isaacs WB, Bova GS, et al. CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: a new prostate cancer biomarker. Cancer Epidem Biomar Prev. 1997;6:443–450. PMID:9184779
   PubMed Web of Science ®Google Scholar
• Fackler MJ, Lopez Bujanda Z, Umbricht C, et al. Novel methylated biomarkers and a robust assay to detect circulating tumor DNA in metastatic breast cancer. Cancer Res. 2014;74:2160–2170. doi:10.1158/0008-5472.CAN-13-3392. PMID:24737128
   PubMed Web of Science ®Google Scholar
• Wielscher M, Vierlinger K, Kegler U, et al. Diagnostic Performance of Plasma DNA Methylation Profiles in Lung Cancer, Pulmonary Fibrosis and COPD. EBioMedicine. 2015;2:929–936. doi:10.1016/j.ebiom.2015.06.025. PMID:26425700
   PubMed Web of Science ®Google Scholar
• Lange CP, Campan M, Hinoue T, et al. Genome-scale discovery of DNA-methylation biomarkers for blood-based detection of colorectal cancer. PLoS One. 2012;7:e50266. doi:10.1371/journal.pone.0050266. PMID:23209692
   PubMed Web of Science ®Google Scholar
• Kisiel JB, Raimondo M, Taylor WR, et al. New DNA methylation markers for pancreatic cancer: discovery, tissue validation, and pilot testing in pancreatic juice. Clin Cancer Res. 2015;21:4473–4481. doi:10.1158/1078-0432.CCR-14-2469. PMID:26023084
   PubMed Web of Science ®Google Scholar
• Sanchez-Vega F, Gotea V, Petrykowska HM, et al. Recurrent patterns of DNA methylation in the ZNF154, CASP8, and VHL promoters across a wide spectrum of human solid epithelial tumors and cancer cell lines. Epigenetics. 2013;8:1355–1372. doi:10.4161/epi.26701. PMID:24149212
   PubMed Web of Science ®Google Scholar
• Irizarry RA, Ladd-Acosta C, Wen B, et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet. 2009;41:178–186. doi:10.1038/ng.298. PMID:19151715
   PubMed Web of Science ®Google Scholar
• Heyn H, Vidal E, Ferreira HJ, et al. Epigenomic analysis detects aberrant super-enhancer DNA methylation in human cancer. Genome Biol. 2016;17:11. doi:10.1186/s13059-016-0879-2. PMID:26813288
   PubMed Web of Science ®Google Scholar
• Li X, Liu Y, Salz T, et al. Whole-genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver. Genome Res. 2016;26:1730–1741. doi:10.1101/gr.211854.116. PMID:27737935
   PubMed Web of Science ®Google Scholar
• NCI, NHGRI, NIH. The Cancer Genome Atlas. Bethesda (MD): NIH, National Cancer Institute, National Human Genome Research Institute; 2016.
   Google Scholar
• Lofton-Day C, Model F, Devos T, et al. DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem. 2008;54:414–423. doi:10.1373/clinchem.2007.095992. PMID:18089654
   PubMed Web of Science ®Google Scholar
• Warren JD, Xiong W, Bunker AM, et al. Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer. BMC Med. 2011;9:133. doi:10.1186/1741-7015-9-133. PMID:22168215
   PubMed Web of Science ®Google Scholar
• Payne SR, Serth J, Schostak M, et al. DNA methylation biomarkers of prostate cancer: confirmation of candidates and evidence urine is the most sensitive body fluid for non-invasive detection. Prostate. 2009;69:1257–1269. doi:10.1002/pros.20967. PMID:19459176
   PubMed Web of Science ®Google Scholar
• Wu T, Giovannucci E, Welge J, et al. Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis. Br J Cancer. 2011;105:65–73. doi:10.1038/bjc.2011.143. PMID:21654682
   PubMed Web of Science ®Google Scholar
• Van Neste L, Herman JG, Otto G, et al. The epigenetic promise for prostate cancer diagnosis. Prostate. 2012;72:1248–1261. doi:10.1002/pros.22459. PMID:22161815
   PubMed Web of Science ®Google Scholar
• Ohm JE, McGarvey KM, Yu X, et al. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet. 2007;39:237–242. doi:10.1038/ng1972. PMID:17211412
   PubMed Web of Science ®Google Scholar
• Schlesinger Y, Straussman R, Keshet I, et al. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet. 2007;39:232–236. doi:10.1038/ng1950. PMID:17200670
   PubMed Web of Science ®Google Scholar
• Vrba L, Munoz-Rodriguez JL, Stampfer MR, et al. miRNA gene promoters are frequent targets of aberrant DNA methylation in human breast cancer. PLoS One. 2013;8:e54398. doi:10.1371/journal.pone.0054398. PMID:23342147
   PubMed Web of Science ®Google Scholar
• Huang YW, Liu JC, Deatherage DE, et al. Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 oncogene in endometrial cancer. Cancer Res. 2009;69:9038–9046. doi:10.1158/0008-5472.CAN-09-1499. PMID:19887623
   PubMed Web of Science ®Google Scholar
• Bandres E, Agirre X, Bitarte N, et al. Epigenetic regulation of microRNA expression in colorectal cancer. Int J Cancer. 2009;125:2737–2743. doi:10.1002/ijc.24638. PMID:19521961
   PubMed Web of Science ®Google Scholar
• Wong KY, Yim RL, Kwong YL, et al. Epigenetic inactivation of the MIR129-2 in hematological malignancies. J Hematol Oncol. 2013;6:16. doi:10.1186/1756-8722-6-16. PMID:23406679
   PubMed Web of Science ®Google Scholar
• Lu CY, Lin KY, Tien MT, et al. Frequent DNA methylation of MiR-129-2 and its potential clinical implication in hepatocellular carcinoma. Genes Chromosom Cancer. 2013;52:636–643. PMID:23580407
   PubMed Web of Science ®Google Scholar
• Furuta M, Kozaki KI, Tanaka S, et al. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis. 2010;31:766–776. doi:10.1093/carcin/bgp250. PMID:19843643
   PubMed Web of Science ®Google Scholar
• Kitano K, Watanabe K, Emoto N, et al. CpG island methylation of microRNAs is associated with tumor size and recurrence of non-small-cell lung cancer. Cancer Sci. 2011;102:2126–2131. doi:10.1111/j.1349-7006.2011.02101.x. PMID:21917081
   PubMed Web of Science ®Google Scholar
• Gebauer K, Peters I, Dubrowinskaja N, et al. Hsa-mir-124-3 CpG island methylation is associated with advanced tumours and disease recurrence of patients with clear cell renal cell carcinoma. Br J Cancer. 2013;108:131–138. doi:10.1038/bjc.2012.537. PMID:23321515
   PubMed Web of Science ®Google Scholar
• Wilting SM, van Boerdonk RA, Henken FE, et al. Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer. Mol Cancer. 2010;9:167. doi:10.1186/1476-4598-9-167. PMID:20579385
   PubMed Web of Science ®Google Scholar
• Wang P, Chen L, Zhang J, et al. Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1. Oncogene. 2014;33:514–524. doi:10.1038/onc.2012.598. PMID:23334332
   PubMed Web of Science ®Google Scholar
• Kang S, Li Q, Chen Q, et al. CancerLocator: non-invasive cancer diagnosis and tissue-of-origin prediction using methylation profiles of cell-free DNA. Genome Biol. 2017;18:53. doi:10.1186/s13059-017-1191-5. PMID:28335812
   PubMed Web of Science ®Google Scholar
• Team RC. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2015.
   Google Scholar
• Teschendorff AE, Marabita F, Lechner M, et al. A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data. Bioinformatics. 2013;29:189–196. doi:10.1093/bioinformatics/bts680. PMID:23175756
   PubMed Web of Science ®Google Scholar
• Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013;14:R115.
   PubMed Web of Science ®Google Scholar
• Smyth GK. Limma: linear models for microarray data. In: Gentleman RCV, Huber W, Irizarry R, Dudoit S, editors. Bioinformatics and computational biology solutions using R and bioconductor. New York: Springer; 2005. p. 397–420.
   Google Scholar
• Robin X, Turck N, Hainard A, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77. doi:10.1186/1471-2105-12-77. PMID:21414208
   PubMed Web of Science ®Google Scholar